Advertisement

Topics

Cross Atlantic Capital Partners Company Profile

00:28 EDT 20th September 2018 | BioPortfolio

Cross Atlantic Capital Partners is a venture capital firm investing in early- to mid-stage technology companies and has proven that it adds significant value to its portfolio companies. XACP’s philosophy that great companies are built over time and require attention to facets of their operations, has led XACP to participate in portfolio company developments, including management team recruitment, introductions, strategic and tactical management assistance, contact resources, expertise in private equity and public financing, and proactive exit management. For more information about Cross Atlantic Technology Partners, please visit www.xacp.com.


News Articles [1922 Associated News Articles listed on BioPortfolio]

Aleph Capital and Crestview Partners Agree to €260M Equity Funding Commitment in DARAG to ...

LONDON and NEW YORK, July 30, 2018 /PRNewswire/ -- Aleph Capital Partners LLP ("Aleph Capital") and Crestview Partners ("Crestview") have today announced that funds under Read more...

Medigene-Aktie: Rückzug von Leerverkäufer GSA Capital Partners hat an Dynamik gewonnen!

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP hat Netto-Leerverkaufsposition in Medigene-Aktien stark verringert: Die Leerverkäufer des Hedgefonds GSA Capital Partners L....

Medigene: Leerverkäufer GSA Capital Partners hat sich deutlich zurückgezogen

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP verringert Netto-Leerverkaufsposition in Medigene-Aktien signifikant: Die Leerverkäufer des Hedgefonds GSA Capital Partners....

CStone closes $260mm Series B round; largest in Chinese biopharm history

Immuno-oncology firm CStone Pharmaceuticals Co. Ltd. raised $260mm through its Series B round, the largest funding of its kind in Chinese biopharma history. GIC Private Ltd. led and was joined by new ...

Oversubscribed Series B brings $110mm to Precision BioSciences

Precision BioSciences (gene editing) raised $110mm through an oversubscribed Series B round. ArrowMark Partners led and was joined by new investors Franklin Templeton Investments, Cowen Healthcare Inv...

Medigene-Aktie: Short-Attacke von GSA Capital Partners geht weiter

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP stockt Netto-Leerverkaufsposition in Medigene-Aktien nun deutlicher auf: Die Leerverkäufer des Hedgefonds GSA Capital Partn....

TCR2 closes $125mm Series B round

TCR2 Therapeutics Inc. (immuno-oncology) raised $125mm through its Series B round. Curative Ventures and 6 Dimensions Capital co-led and were joined by additional new investors Redmile Group, ArrowMar...

Brii Biosciences launches with $260mm

Brii Biosciences has launched with committed funding of $260mm from Arch Venture Partners, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital, Sequoia Capital, and Blue Pool Capital.

PubMed Articles [1156 Associated PubMed Articles listed on BioPortfolio]

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

Is community social capital associated with subjective symptoms of dementia among older people? A cross-sectional study in Japan.

Many studies have reported the preventive effects of community social capital on health outcomes, such as mortality and incidence of diseases. However, evidence on the association between community so...

A comparative study of social capital and hospital readmission in older adults.

Numerous factors contribute to hospital readmissions of older adults. The role social capital may play in preventing hospital readmissions is unknown. The aim of this descriptive, cross-sectional stud...

Alcohol intake among adolescent students and association with social capital and socioeconomic status.

The aim was to evaluate the prevalence of alcohol consumption, binge drinking and their association with social capital and socioeconomic factors among Brazilian adolescents students. A cross-sectiona...

Joint Action in a Virtual Environment: Crossing Roads with Risky vs. Safe Human and Agent Partners.

This paper examined how people jointly coordinate their decisions and actions with risky vs. safe human and agent road-crossing partners (Fig. 1). The task for participants was to physically cross a s...

Clinical Trials [1865 Associated Clinical Trials listed on BioPortfolio]

Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

ID & Testing in Male Partners

This pilot study is a sub-study of ATN 067. ATN 067 utilizes a cross-sectional research design to recruit Latina and African American young women to undergo HIV screening. The primary goal...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Companies [2302 Associated Companies listed on BioPortfolio]

Cross Atlantic Capital Partners

Cross Atlantic Capital Partners is a venture capital firm investing in early- to mid-stage technology companies and has proven that it adds significant value to its portfolio comp...

Mid-Atlantic Dental Partners

“Mid-Atlantic Dental Partners will enable dentists to participate in improving the delivery of dental care by spending more time serving their patients instead of handling bi...

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

Skada Capital

Skada Capital (www.skadacapital.com) is a Maryland-based provider of financing solutions to healthcare, government contracting and technology companies in the Mid-Atlantic ...

General Atlantic LLC

General Atlantic is a leading global growth equity firm providing capital and strategic support for growth companies. GA combines a collaborative global approach, sector specific expertise, long-term ...

More Information about "Cross Atlantic Capital Partners" on BioPortfolio

We have published hundreds of Cross Atlantic Capital Partners news stories on BioPortfolio along with dozens of Cross Atlantic Capital Partners Clinical Trials and PubMed Articles about Cross Atlantic Capital Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cross Atlantic Capital Partners Companies in our database. You can also find out about relevant Cross Atlantic Capital Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record